Close Menu

NEW YORK – Stock prices for many diagnostics firms rebounded in June after the broader markets pushed down their share values the month before.

The 360Dx Index rose nearly 9 percent month over month in June, bouncing back from a decline of almost 3 percent in May. It outpaced the Dow Jones Industrial Average and the Nasdaq , both of which rose about 7 percent, but trailed the Nasdaq Biotech Index which climbed slightly more than 9 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.